ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

NCT06118281 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

10000

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Risk
Acute Myocardial Infarction (AMI)

Interventions

DRUG: Ziltivekimab
DRUG: Placebo

Sponsor

Novo Nordisk A/S

Collaborators

[object Object]